Printed From:

SOLIQUA 100/33 works 5 ways to help deliver blood control sugar and lower your A1 illustration

SOLIQUA 100/33 works 5 ways in your body

SOLIQUA 100/33 works 5 ways to deliver blood sugar control and help lower A1c.

  1. Bloodstream Helps reduce sugar buildup in your bloodstream
  2. Stomach Slows down the process by which sugar enters your bloodstream after eating
  3. Liver Helps slow down the processes by which the liver releases sugar into the bloodstream
  4. Pancreas Helps your pancreas release more insulin to help maintain lower blood sugar levels
  5. Muscles Helps muscles store glucose that your body doesn’t need right away so it can be used for energy later

Should you switch to SOLIQUA 100/33? Ask your doctor.

SOLIQUA 100/33 is proven to lower A1c to below 7%*graph

SOLIQUA 100/33 is proven to lower A1c below 7%

In a clinical study, more than half (55%) of patients using SOLIQUA 100/33 lowered their A1c below 7%, while 30% of patients using Lantus® reached an A1c below 7%. On average, A1c was reduced from a starting point of 8.1% to 6.9% in patients taking SOLIQUA 100/33 and 8.1% to 7.5% in Lantus® patients.

Your doctor may prescribe a dose of insulin that is different from the doses used in the study. The differences between Lantus® and SOLIQUA 100/33 seen in the trial may not reflect your results.

Individual results may vary.

 

Almost twice the A1c reduction of
Lantus® alone

2X Almost twice the A1c REDUCTION
 

In the same clinical study, patients using SOLIQUA 100/33 achieved almost twice the A1c reduction than patients who were using Lantus®.

The clinical study showed how adding a non-insulin diabetes medicine to Lantus®, a long-acting insulin, in a single injection improves blood sugar control. The study involved 1,036 patients with type 2 diabetes who had been taking a long-acting insulin for 6 or more months, but had still not reached their A1c goal. After 6 weeks of taking Lantus® at a dose of 60 units or less daily, 736 patients who had still not achieved their A1c goal and had a fasting blood sugar ≤140 mg/mL continued in the study. For the next 30 weeks, half of the patients continued on Lantus® and half received SOLIQUA 100/33 (Lantus® + non-insulin medicine). The study showed that combining a non-insulin diabetes medicine with Lantus® may help to lower blood sugar even further.


What you should know about the possible side effects of SOLIQUA 100/33

The most common side effects of SOLIQUA 100/33 may include low blood sugar (hypoglycemia), nausea, headache, stuffy or runny nose and sore throat, allergic reactions, diarrhea, and upper respiratory tract infection.

Nausea and diarrhea usually happen more often when you start using SOLIQUA 100/33.

SOLIQUA 100/33 delivers blood sugar control through the day and night clock icon

Helps manage blood sugar all day and night

SOLIQUA 100/33 delivers blood sugar control throughout the day and night.